Agonist-specific coupling

 Agonist-specific coupling

On the other hand, receptors may be promiscuous as well and couple to more than one G protein. Many receptors appear to be pre-associated with G proteins in the absence of agonists. The pre-bound G protein may in turn change the conformation of the entire receptor and thus modify its affinity for mediator and drug molecules. If there is more than one type of G protein to couple to a given receptor, this may result in several sub-populations of the receptor that may exhibit diverging affinities for different agonists. This behaviour is known as `agonist-specific coupling'.

 

An example of agonist-specific coupling is shown in Fig-ure 8.3. The receptor in question is the α1A-adrenergic re-ceptor. This receptor triggers at least two different intracel-lular signaling pathways: Arachidonic acid is released by phospholipase A2, and inositoltriphosphate (IP3) is released by phospholipase C. These two effects are mediated by two different G proteins that couple to the same receptor. If we compare the two parameters, the three compounds nore-pinephrine and meta- and para-octopamine yield substan-tially different potencies and efficacies. If we hadn't been told otherwise, we would interpret this observation as evi-dence of two different receptors. In a sense, of course, dif-ferent GPCR-G protein complexes are different receptors.


Comments

Popular posts from this blog

Drugs and drug target molecules

Drug molecules may or may not have physiological counterparts

Ion gradients across the cell plasma membrane